New ultrasound agent matches nuclear medicine
This article was originally published in Clinica
Preclinical studies show that Acusphere's new ultrasound contrast agent has the potential to simplify contrast echocardiography because it can be detected continuously after bolus administration. Trials of AI-700 in dogs show that gas-filled synthetic polymer microspheres detect areas of low blood flow in the heart muscle, in high agreement with nuclear medicine, the current gold standard for detecting heart prefusion defects, say cardiologists at Tufts-New England Medical Center in Boston.
You may also be interested in...
The FDA’s OPQ touts approval of sixth and seventh continuously manufactured drugs and quicker delivery of inspection results in latest annual report.
No device-related warning letters were released by the US FDA the week of 19 February.
Complex generics and value added medicines share common challenges on harmonization of regulation, lack of incentives and clarity of guidelines, heard delegates to Medicines for Europe’s Regulatory & Scientific Affairs conference.